1. Home
  2. CPB vs HALO Comparison

CPB vs HALO Comparison

Compare CPB & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$21.12

Market Cap

8.8B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$63.23

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPB
HALO
Founded
1869
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.8B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
CPB
HALO
Price
$21.12
$63.23
Analyst Decision
Hold
Buy
Analyst Count
16
11
Target Price
$27.75
$78.18
AVG Volume (30 Days)
8.8M
1.4M
Earning Date
03-11-2026
05-05-2026
Dividend Yield
7.42%
N/A
EPS Growth
6.35
N/A
EPS
1.13
2.56
Revenue
$10,253,000,000.00
$151,862,000.00
Revenue This Year
N/A
$28.24
Revenue Next Year
$0.97
$12.79
P/E Ratio
$18.61
$24.75
Revenue Growth
6.40
N/A
52 Week Low
$20.87
$47.50
52 Week High
$40.59
$82.22

Technical Indicators

Market Signals
Indicator
CPB
HALO
Relative Strength Index (RSI) 21.81 31.02
Support Level N/A $61.23
Resistance Level $33.65 $65.40
Average True Range (ATR) 0.67 1.74
MACD -0.35 -0.35
Stochastic Oscillator 4.26 7.10

Price Performance

Historical Comparison
CPB
HALO

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: